ArticleCancer2009

Survival is poorer in patients with secondary core-binding factor acute myelogenous leukemia compared with de novo core-binding factor leukemia.

Gautam Borthakur et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.